Physician profile
Chirag Devendra Shah
NPI 1477995264
$48,480.15
in general payments reported to CMS, 2019-2025
5 companies · $4,168 in 2025
The $4,168 reported for 2025 was more than what 93% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,591 · 2022: $9,375 · 2023: $13K · 2024: $13K · 2025: $4,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,287.50 |
| Food and Beverage | $227.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47,995.41 | 2021-2025 | Lynparza, Verquvo, Capvaxive |
| Medtronic, INC. | $175.00 | 2022 | |
| Vertos Medical, INC. | $174.66 | 2022 | |
| Relievant Medsystems, INC. | $119.43 | 2023 | Intracept |
| Itamar Medical INC | $15.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.